|
Market Closed -
Toronto S.E.
15:22:49 19/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | 0.00% |
|
+1.01% | +9.89% |
Company Valuation: PharmaCorp Rx Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 63.34 | 75.95 | 87.04 | - | - |
| Change | - | 19.91% | 14.6% | - | - |
| Enterprise Value (EV) 1 | 63.34 | 53.55 | 91.94 | 88.46 | 90.87 |
| Change | - | -15.46% | 71.71% | -3.78% | 2.72% |
| P/E | -54x | -45.5x | 50x | 16.7x | - |
| PBR | - | - | 1.56x | 1.47x | - |
| PEG | - | - | -0x | 0x | - |
| Capitalization / Revenue | - | 3.64x | 1.75x | 0.89x | 1x |
| EV / Revenue | - | 2.56x | 1.85x | 0.9x | 1.05x |
| EV / EBITDA | - | 15.2x | 18.7x | 7.91x | 7.99x |
| EV / EBIT | - | - | 41.5x | 12.4x | 10.8x |
| EV / FCF | - | 27.9x | -38.3x | 16.8x | 12.8x |
| FCF Yield | - | 3.58% | -2.61% | 5.95% | 7.84% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.01 | -0.01 | 0.01 | 0.03 | - |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | 20.89 | 49.82 | 98.11 | 86.65 |
| EBITDA 1 | - | 3.528 | 4.911 | 11.18 | 11.37 |
| EBIT 1 | - | - | 2.215 | 7.13 | 8.448 |
| Net income 1 | -1.013 | -1.481 | 1.6 | 7 | - |
| Net Debt 1 | - | -22.4 | 4.903 | 1.424 | 3.828 |
| Reference price 2 | 0.5400 | 0.4550 | 0.5000 | 0.5000 | 0.5000 |
| Nbr of stocks (in thousands) | 117,296 | 166,927 | 174,082 | - | - |
| Announcement Date | 22/04/25 | 29/04/26 | - | - | - |
1CAD in Million2CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 50x | 1.85x | 18.72x | - | 62.98M | |
| 17.8x | 0.75x | 11.16x | -.--% | 15.82B | |
| 21.72x | 0.84x | 14.15x | 1.03% | 6.71B | |
| 16.33x | 0.74x | 7.74x | 2.28% | 6.26B | |
| 14.97x | 0.98x | 7.08x | 2.83% | 4.32B | |
| 14.47x | 1.24x | 7.6x | 5.56% | 3.22B | |
| 13.74x | 0.56x | 4.49x | 5.03% | 3.03B | |
| 14.36x | 0.86x | 6.5x | 4.47% | 3.03B | |
| 30.93x | - | - | - | 2.41B | |
| Average | 21.59x | 0.98x | 9.68x | 3.03% | 4.98B | |
| Weighted average by Cap. | 17.91x | 0.82x | 9.65x | 1.89% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PCRX Stock
- Valuation PharmaCorp Rx Inc.
Select your edition
All financial news and data tailored to specific country editions
